Fostamatinib is an experimental drug candidate for the treatment of a variety of diseases, originally developed by Rigel Pharmaceuticals. The drug is administered orally as a disodium salt, and is a prodrug of the active compound tamatinib (R-406), which is an inhibitor of the enzyme spleen tyrosine kinase (Syk), hence it is an syk inhibitor.

CAS：1025687-58-4
中文别名：
英文别名：Fostamatinib disodium;R788 (Fostamatinib) Disodium;R 788 sodium;R788;R788,FosD,tamatinib fosdium;R788(prodrug of R406);
分子式：C23H24FN6Na2O9P
分子量：624.423
精确质量：624.112
Psa：205.42
Logp：3.5308

外观性状：粉末
储存条件：-20℃